OMUFA - Screening Non-Sterile OTC Monograph Products for Microbial Contamination
Type: Forecast
Overview
Description
OMUFA - A study will be designed to evaluate non-sterile, aqueous based, OTC monographdrugs for microbial contamination. This will enhance FDA's surveillance of OTC monograph products andpotentially reduce the incidence of adverse events.
Est. Value
Min: $250,000
Max: $700,000
Max: $700,000
Est. Award Date
9/1/26
Source Est. Solicitation Date
7/1/26
Set Aside
To be determined
Forecast Type
New
Forecast Source
Health and Human Services
Centers for Disease Control and Prevention is forecasted to issue a new procurement for OMUFA - Screening Non-Sterile OTC Monograph Products for Microbial Contamination around 9/1/26 worth up to $700,000.
Agency
Source Level 1 Agency
Health and Human Services
Source Level 2 Agency
Centers for Disease Control and Prevention
Contacts
Potential Bidders and Partners
Similar Active Opportunities
Additional Detail
Date Published
11/19/25